Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic cash
Cash and short-term investments held at the end of each period.
Medtronic's cash was $8.82B at Jul 31, 2026. For fiscal 2026 it was $9.22B, up 2.8% from the year before. Over ten years it grew -3.1% a year on average. The highest annual figure on record is $19.48B in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $9.22B | +2.8% |
| FY2025 | Apr 25, 2025 | $8.97B | +12.0% |
| FY2024 | Apr 26, 2024 | $8.01B | +0.6% |
| FY2023 | Apr 28, 2023 | $7.96B | -24.7% |
| FY2022 | Apr 29, 2022 | $10.57B | -2.3% |
| FY2021 | Apr 30, 2021 | $10.82B | -1.2% |
| FY2020 | Apr 24, 2020 | $10.95B | +11.2% |
| FY2019 | Apr 26, 2019 | $9.85B | -12.3% |
| FY2018 | Apr 27, 2018 | $11.23B | -18.1% |
| FY2017 | Apr 28, 2017 | $13.71B | +8.5% |
| FY2016 | Apr 29, 2016 | $12.63B | -35.1% |
| FY2015 | Apr 24, 2015 | $19.48B | +36.8% |
| FY2014 | Apr 25, 2014 | $14.24B | +1449.6% |
| FY2013 | Apr 26, 2013 | $919.00M | -21.6% |
| FY2012 | Apr 27, 2012 | $1.17B | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $8.82B | +8.6% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $9.22B | +2.8% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $8.38B | +5.8% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $8.33B | +4.2% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $8.12B | +3.5% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $8.97B | +12.0% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $7.92B | -4.8% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $7.99B | +3.3% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $7.84B | -0.4% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $8.01B | +0.6% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $8.32B | -25.3% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $7.73B | -32.3% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $7.88B | -11.2% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $7.96B | -24.7% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $11.14B | -0.7% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $11.43B | +7.1% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $8.87B | -16.3% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $10.57B | -2.3% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $11.22B | -23.3% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $10.67B | -25.3% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $10.60B | -18.6% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $10.82B | -1.2% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $14.64B | +25.9% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $14.28B | +37.3% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $13.01B | +21.8% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $10.95B | +11.2% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $11.63B | +27.2% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $10.40B | +2.6% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $10.68B | -2.9% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $9.85B | -12.3% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $9.14B | -36.7% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $10.13B | -25.1% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $11.00B | -15.9% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $11.23B | -18.1% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $14.44B | +26.0% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $13.53B | +20.2% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $13.09B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $13.71B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $11.46B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $11.26B | – |
See a number that looks wrong?